Researchers at the Hebrew University of Jerusalem have recently developed a breakthrough drug to treat acute myeloid leukemia (AML), one of the most aggressive cancers, Yisroel Hayom reports.

Professor Yinon Ben-Neriah, who heads the research team, said the new drug “targets many leukemia proteins at once and destroys all of the oncogenes [that have the potential to cause cancer], and activates the tumor suppressor P53 gene.”

Researchers are trying to expand the drug’s use to other cancers, including lymphoma, multiple myeloma, melanoma and colorectal cancer.